![]() |
|
|
Vol. 30, Issue 3, 295-300, March 2002
Department of Pharmacy, Division of Pharmaceutical Chemistry,
University of Helsinki, Finland (S.K., J.T.); and Orion Pharma,
Preclinical and Clinical Research and Development, Turku, Finland
(J.S.S.)
N-Glucuronidation in vitro of six
4-arylalkyl-1H-imidazoles (both enantiomers of
medetomidine, detomidine, atipamezole, and two other closely
related compounds) by rat, dog, and human liver microsomes and by four
expressed human UDP-glucuronosyltransferase isoenzymes was studied.
Human liver microsomes formed N-glucuronides of
4-arylalkyl-1H-imidazoles with high activity, with
apparent Vmax values ranging from 0.59 to
1.89 nmol/min/mg of protein. In comparison, apparent
Vmax values for two model compounds forming the N-glucuronides 4-aminobiphenyl and amitriptyline
were 5.07 and 0.56 nmol/min/mg of protein, respectively. Atipamezole
showed an exceptionally low apparent Km
value of 4.0 µM and a high specificity constant
(Vmax/Km) of 256 compared with 4-aminobiphenyl (Km, 265 µM;
Vmax/Km, 19) and
amitriptyline (Km, 728 µM;
Vmax/Km, 0.8). N-Glucuronidation of medetomidine was highly
enantioselective in human liver microsomes; levomedetomidine exhibited
a 60-fold Vmax/Km
value compared with dexmedetomidine. Furthermore, two isomeric
imidazole N-glucuronides were formed from
dexmedetomidine, but only one was formed from levomedetomidine. Dog
liver microsomes formed N-glucuronides of
4-arylalkyl-1H-imidazoles at a low rate and affinity,
with apparent Vmax values ranging from 0.29 to 0.73 nmol/min/mg of protein and apparent
Km values from 279 to 1640 µM. Rat liver
microsomes glucuronidated these compounds at a barely detectable rate.
Four expressed human UDP-glucuronosyltransferase isoenzymes (UGT1A3,
UGT1A4, UGT1A6, and UGT1A9) were studied for 4-arylalkyl-1H-imidazole-conjugating activity. Only
UGT1A4 glucuronidated these compounds at an activity of about 5% of
that measured for 4-aminobiphenyl. The observed activity of UGT1A4 does
not explain the high efficiency of glucuronidation of
4-arylalkyl-1H-imidazoles in human liver microsomes.
This article has been cited by other articles:
![]() |
A.-S. Patana, M. Kurkela, M. Finel, and A. Goldman Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases Protein Eng. Des. Sel., September 1, 2008; 21(9): 537 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaivosaari, P. Toivonen, O. Aitio, J. Sipila, M. Koskinen, J. S. Salonen, and M. Finel Regio- and Stereospecific N-Glucuronidation of Medetomidine: The Differences between UDP Glucuronosyltransferase (UGT) 1A4 and UGT2B10 Account for the Complex Kinetics of Human Liver Microsomes Drug Metab. Dispos., August 1, 2008; 36(8): 1529 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alonen, O. Aitio, K. Hakala, L. Luukkanen, M. Finel, and R. Kostiainen BIOSYNTHESIS OF DOBUTAMINE MONOGLUCURONIDES AND GLUCURONIDATION OF DOBUTAMINE BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., May 1, 2005; 33(5): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaji and T. Kume CHARACTERIZATION OF AFLOQUALONE N-GLUCURONIDATION: SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM(S) Drug Metab. Dispos., January 1, 2005; 33(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4 Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79. [Abstract] [Full Text] [PDF] |
||||